Managers
UK private equity manager Maven Capital Partners (Maven) has invested GBP1.5 million in Gen inCode, a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease.
Gen inCode raised in total GBP3.4 million, where Maven invested alongside another institutional investor and existing private shareholders.
Gen inCode has developed a range of patented DNA risk assessment products which utilise AI, bioinformatics and a globally recognised clinical evidence base to provide predictive analysis of a patient’s health risk. Proprietary algorithms are used to predict the probability of adverse events, resulting in a comprehensive risk evaluation that provides key insights
MidOcean Partners, a middle market private equity firm focused on the business services and consumer sectors, has acquired Music Reports, an independent provider of music rights data, administration, and management services, from ABRY Partners and the company’s co-founders, Ronald Gertz and Douglas Brainin. MidOcean’s investment will be used to accelerate Music Reports’ growth, both through organic product initiatives, as well as potential acquisitions. Financial terms of the transaction have not been disclosed.
Music Reports leverages its proprietary and continuously updated music and cue sheet databases, Songdex and Cuetrak, to deliver a full technology-enabled platform of advanced rights, payments, and royalty solutions
Private investment firm GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.Headquartered in Horsham, Pennsylvania, Clinical Ink offers data certainty from source to submission during clinical trials. The company’s Lumenis eSource clinical technology is a suite of solutions for capturing and integrating clinical trial electronic study data from sites, clinicians, and patients in real time. Through configurable direct data capture (DDC), electronic clinical outcome assessment (eCOA), electronic patient reported outcomes (ePRO), and eConsent modules, the company’s eSource Ecosystem has been deployed across 300 studies, in all Phases (I–IV).
In partnership with
kSARIA Corporation (kSARIA), a producer and supplier of mission-critical connectivity solutions for the aerospace and defence end markets and a portfolio company of Behrman Capital, has acquired Compulink Cable Assemblies (Compulink). Financial terms of the transaction have not been disclosed.Headquartered in St Petersburg, Florida, Compulink is an AS9100-registered manufacturer of high-reliability cables and harnesses for commercial and military applications. Since 1984, Compulink has served original equipment manufacturers nationwide with excellence in design engineering, prototype fabrication, production, and testing. The Company’s product capabilities include an array of harness assemblies such as coax, RF, Mil-C-38999 and miniaturised connectors, as well as custom-moulded
Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, has completed an oversubscribed USD18.4 million private financing round. Participation included new and existing investors, inclusive of family offices from the US, Europe and Asia-Pacific, and high net worth individuals.
Robert Fallon, President and Chief Executive Officer of Phosplatin Therapeutics, says: “The success of the financing underscores the breadth of our data from three different Phase I trials and the broad potential of our lead compound, PT-112, which is advancing through clinical development as a monotherapy, including in mCRPC and multiple myeloma, and in combination with PD-L1 immune checkpoint inhibition.
Texas-based private investment firm Andros Capital Partners closed its energy-focused inaugural investment fund Andros Energy Capital at its USD250 million hard cap last week. Private Equity Wire caught up with founder Phillip A Gayle JR (pictured) to find out about current developments within the energy sector, where the opportunities are and his thoughts on the new normal.
Apex Group (Apex), a global financial services provider, has been appointed to provide full fund administration services to Preservation Capital Partners (Preservation Capital).Fund administration is at the core of Apex’s offering, providing clients with timely, accurate and independent portfolio administration using innovative technology and highly qualified personnel with local expertise.
Preservation Capital, a specialist investor in the asset-light financial services sector, last month announced the closing of its debut fund, Preservation Capital Partners Fund I at its hard cap of GBP309 million (USD400 million).
Apex’s fully integrated global fund administration system and high-speed, real-time processing enables the delivery
Apparis, a vegan fashion brand best known for its bold and colourful faux fur coats, has closed a USD3 million seed round funding, led by Third Kind Venture Capital.Founded in 2016 and based in New York City, Apparis has quickly grown a cult following for their high quality, high fashion, and cruelty-free outerwear.
This seed round was led by Third Kind Venture Capital, with a major investment from Exor Seeds, the venture fund affiliated with the Agnelli family. Several angel investors participated in the round, among them Karlie Kloss (supermodel and entrepreneur), Francesco Carozzini (Italian director and photographer), and Cam
Warburg Pincus, a global private equity firm focused on growth investing, and Martis Capital, a private equity firm focused exclusively on the healthcare sector, have agreed to merge their respective portfolio companies, Qualifacts and Credible Behavioral Health. The combination of these best-in-class technology companies will elevate the experience of behavioural health and human service providers while positioning the combined company for continued innovation and thought leadership in the market.
The company will be led by David Klements, CEO of Qualifacts. Matthew Dorman, CEO of Credible, will continue as a strategic advisor to the company.
“Qualifacts and Credible are highly regarded in
Ara Partners, a private equity firm specialising in decarbonisation investments, has made a majority investment in Path Environmental Technology (Path), an industrial services provider headquartered in Houston, Texas. Financial terms of the transaction have not been disclosed.
Path, founded in 2014 and formerly known as Sweat Energy Services, cleans above ground storage tanks (ASTs) and rail tank cars using proprietary methods to reduce greenhouse gas emissions, waste generation and hazardous man hours. Path’s differentiated service offering—unique technologies coupled with highly trained personnel—serves the agriculture, chemical, food & beverage, petrochemical, pulp & paper and refining industries throughout North America.
In
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
